Authors


Frank Sheppard

Latest:

Unique Considerations for Specialized Patient Populations for Pharmacies Utilizing Appointment-Based Care Models: Part 2

While there is a reasonable body of research on many of the diverse causes of medication nonadherence, there are much fewer data on the effectiveness of various interventions.


Laurie Toich, Assistant Editors

Latest:

Biosimilars May Change the Treatment Landscape for Inflammatory Diseases

Clinician and patient understanding and access considerations represent the most significant hurdles inhibiting the uptake of biosimilars for inflammatory conditions.


Sean Johnson

Latest:

UnitedHealthcare Bars Copay Coupons for Specialty Drugs

According to a report by Elsevier's Business Intelligence, UnitedHealthcare has announced that pharmacies that are participating in its Designated Specialty Pharmacy network will no longer redeem manufacturer-sponsored coupons.


Cristina Masseria, PhD

Latest:

Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial Fibrillation

This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.


Alyssa Pirestani

Latest:

What You Need to Know about Hot Tamales Candy

Benzidine-based dyes commonly used in pharmaceuticals are also found in popular candy, which may lead to adverse health issues.




Pedram Pahlavan, PharmD, BSP

Latest:

Specialty Pharmacy By the Numbers

As specialty pharmacies continue to grow, health systems will need to evaluate whether an integrated specialty pharmacy is right for them.


Trang Ho

Latest:

Rx Product News Profile: A Closer Look at New FDA Actions: Bristol-Myers Squibb's and AstraZeneca's Onglyza

Onglyza (saxagliptin) comarketed by Bristol-Myers Squibb and AstraZeneca, is FDA-approved to improve glycemic control for the treatment of type 2 diabetes.


Heather N. Wolf, PharmD Candidate

Latest:

Pharmacists Need to Understand Law Related to Controlled Substances

The Protecting Patient Access to Emergency Medications Act of 2017 Spells Out Appropriate Dispensing Procedures.


Ryan W. Stevens, PharmD, BCIDP

Latest:

Many Platforms Offer Rapid Detection in Bloodstream Infections

Institutions should consider optimal targets, testing volumes, and notification and reporting practices when making their choice.



Kenneth Bender

Latest:

Inconsistent Prior Authorization Affects Attention-Deficit/Hyperactivity Disorder Treatment

Study finds that ADHD treatment recommendations are not always followed.


Michelle Whirl-Carrillo, PhD

Latest:

Pharmacogenetic Resources: PharmGKB and Clinical Pharmacogenetics Implementation Consortium

Pharmacogenetics is the study of how genes impact drug response, an integral part of personalized medicine.


Anna Pulcina, MD

Latest:

Potential Gender Differences of Exenatide in Outpatients With Type 2 Diabetes Mellitus

In outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.



Tina Zerilli, PharmD

Latest:

Zuranolone Offers An Innovative Treatment for Postpartum Depression

Zuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.


Ronald E. Aubert, PhD, MSPH

Latest:

Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid Arthritis

For patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.


Robert Abouassaly, MD

Latest:

Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell Carcinoma

Study investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.


John R. Horn, PharmD, FCCP

Latest:

Estrogens and Lamotrigine: New Developments

Practitioners have known for almost 2 decades that oral contraceptives consistently and substantially reduce the serum concentrations of lamotrigine and may reduce seizure control.



Timothy O'Shea

Latest:

Treatments for Tardive Dyskinesia: What Pharmacists Should Know

There are two recently approved medications for this condition.


Julia K. Nguyen, PharmD

Latest:

Effect of Dispensing Supply on Pravastatin Refill Adherence

In uninsured, indigent, and low-income patients with hyperlipidemia, optimum pravastatin refill adherence was observed with a 90-day dispensing supply.


Dorinda Martin, RPh, PharmD, FACA, FASAP

Latest:

Cost of Dispensing Specialty Drugs May Be More Than You Think

Smaller entrepreneurial pharmacy owners are proactively pursuing the dispensing of specialty medications.


Kristin McMahon, PharmD, MBA

Latest:

Complete Immunization Services Start With Gathering Patient Information

Pharmacy team members have the amazing opportunity to help ensure that people and communities are protected with proper immunizations during influenza (flu) season and beyond, but they may struggle with identifying patients who may benefit because it can be difficult to gather information from patients.


Kristin Coppock, MA, Managing Editor

Latest:

HOPA 2021: New Therapies on the Horizon for Advanced NSCLC

A session at the Hematology/Oncology Pharmacy Association Virtual Annual Conference provided an overview of how treatment options are changing with potential new therapies in development for patients with non-small cell lung cancer.


Jennifer E. MacDonald, PharmD

Latest:

Understanding the Evolving Landscape of Malignant Melanoma

This Continuing Education activity is supported by an educational grant from Merck Sharpe & Dohme Corp.



Christine Kubus, 2016 PharmD Candidate

Latest:

Could Zinc Supplements Help Prevent Febrile Seizures?

Some evidence suggests that a febrile seizure occurs when the child has low serum zinc levels.


Kristina Barakov, PharmD Candidate

Latest:

New Insulin Products and Best Practices

Even with many new developments over the past century, the coordinated use of blood glucose monitors, diabetes medications, and insulin to manage the disease may be too intricate for some patients.